查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613330

除熱原無菌管瓶市場：按類型、容量和最終用戶分類 - 全球預測 2025-2030

Depyrogenated Sterile Empty Vials Market by Type (Glass Vials, Plastic Vials), Capacity (10mL, 20mL, 2mL), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Depyrogen無菌管瓶市值為7.9779億美元，預計到2024年將達到8.4693億美元，複合年成長率為6.67%，到2030年將達到12.5388億美元。

除熱原無菌管瓶市場在藥品製造中發揮重要作用，其特點是為藥品的儲存和分配提供無熱原容器。這些管瓶對於保持注射藥物的完整性和確保患者安全至關重要。生技藥品和疫苗產量的增加增加了生物技術和製藥行業的需求，其應用範圍包括藥物製劑、冷凍乾燥和注射劑的儲存。最終使用領域包括醫院、研發和製藥公司，其中無菌管瓶支援藥物開發和管理的各個階段。關鍵的成長要素包括慢性病的增加、注射藥物的強大管道、政府醫療保健支出的增加以及對患者安全和藥物療效的日益關注。新的發展機會在於開發採用改良材料的管瓶，以提高化學相容性，並更多地採用即用型預灌裝系統，以簡化操作並降低污染風險。然而，市場面臨製造成本高、監管標準嚴格以及供應商必須應對的潛在供應鏈限制等挑戰。市場相關人員應追求智慧包裝的進步並整合物聯網支援的功能來監控和確保即時品質保證。此外，使用環保和永續材料將有助於滿足對環保解決方案不斷成長的需求，使其成為創新的成熟領域。複雜的滅菌過程和監管合規障礙等逆境要求產業相關人員不斷創新並適應技術和程序的變化。為了實現永續成長，相關人員應投資於專注於材料科學創新和自動化生產流程的研發，以滿足精度、擴充性和合規性需求。整體而言，市場格局充滿活力，成長潛力取決於策略性業務調整和技術投資。

主要市場統計
基準年[2023] 7.9779 億美元
預計年份 [2024] 84693萬美元
預測年份 [2030] 1,253,880,000 美元
複合年成長率（%） 6.67%

市場動態：快速發展的去熱原無菌管瓶市場的關鍵市場洞察

供需的動態交互作用正在改變去熱原無菌管瓶市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 製藥和生物技術產業的需求不斷成長
    • 政府機構和私人組織加強促進疫苗接種
  • 市場限制因素
    • 缺乏醫療基礎設施
  • 市場機會
    • 滅菌和去熱原技術的進步
    • 加強對無熱原滅菌管瓶專用包裝的關注
  • 市場挑戰
    • 與仿冒品相關的風險

波特五力：駕馭去熱原無菌管瓶市場的策略工具

波特的五力框架是了解去熱源無菌管瓶市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對去熱原無菌管瓶市場的外部影響

外部宏觀環境因素在塑造 Depyrogen 無菌管瓶市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解去熱原滅菌管瓶市場的競爭狀況

對去熱原滅菌管瓶市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣去熱原無菌管瓶市場供應商的績效評估

FPNV 定位矩陣是評估去熱原無菌管瓶市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了去熱源無菌管瓶市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對 Depyrogen 無菌管瓶市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥和生物技術產業的需求增加
      • 政府和私人組織正在加強促進疫苗接種。
    • 抑制因素
      • 缺乏醫療基礎設施
    • 機會
      • 滅菌和去熱原技術的進步
      • 更重視無熱原滅菌管瓶的特殊包裝
    • 任務
      • 與仿冒品相關的風險
  • 市場區隔分析
    • 類型：擴大使用具有成本效益的塑膠管瓶
    • 最終用戶：在臨床研究中增加使用去熱原的無菌管瓶
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章去熱原滅菌管瓶市場：依照類型

  • 管瓶
  • 塑膠管瓶

第7章去熱原無菌管瓶市場：依容量

  • 10mL
  • 20mL
  • 2mL
  • 5mL

第8章去熱原滅菌管瓶市場：依最終用戶分類

  • 醫療機構
  • 製藥公司
  • 研究/學術實驗室

第9章北美和南美去熱原管瓶市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區去熱原無菌管瓶市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的去熱原無菌管瓶市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • ALK Life Science Solutions 與 Galenova 建立策略合作夥伴關係，銷售除熱原滅菌管瓶
    • 康寧與 SGD Pharma 就新玻璃管廠結成策略聯盟
  • 戰略分析和建議

公司名單

  • Arab Pharmaceutical Glass Co.（APG）
  • Bormioli Pharma
  • Consol Glass
  • Corning Inc.
  • Gerresheimer AG
  • Global Pharmatech Pvt. Ltd.
  • Hindusthan National Glass & Industries Ltd.
  • Nipro Corporation
  • Piramal Glass
  • SCHOTT AG
  • SGD Pharma
  • SGD SAS
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Stevanato Group
  • Thermo Fisher Scientific Inc.
  • Triveni Polymers Pvt. Ltd.
  • West Pharmaceutical Services, Inc.
  • YPSOMED AG
Product Code: MRR-CB04E05659A7

The Depyrogenated Sterile Empty Vials Market was valued at USD 797.79 million in 2023, expected to reach USD 846.93 million in 2024, and is projected to grow at a CAGR of 6.67%, to USD 1,253.88 million by 2030.

The market for depyrogenated sterile empty vials is characterized by its critical role in pharmaceutical manufacturing, offering containers free from pyrogens for drug storage and distribution. These vials are essential in maintaining the integrity of injectable drugs, thus ensuring patient safety. With increasing demand in biotechnology and pharmaceutical industries, driven by the rise in biologics and vaccine production, the application scope encompasses drug compounding, lyophilization, and storage of injectable formulations. End-use sectors include hospitals, research labs, and pharmaceutical companies, where sterile vials support various stages of drug development and administration. Key growth influencers include rising incidences of chronic diseases, a robust pipeline of injectable drugs, escalating governmental health expenditure, and a heightened focus on patient safety and drug efficacy. Emerging opportunities lie in developing vials with improved materials for enhanced chemical compatibility and in the increasing adoption of ready-to-use and prefillable systems, which streamline operations and mitigate contamination risks. However, the market faces challenges such as high production costs, stringent regulatory standards, and potential supply chain constraints that suppliers must navigate. Market players should explore advancements in smart packaging and integrate IoT-enabled features to monitor and ensure real-time quality assurance. Moreover, utilizing eco-friendly and sustainable materials can cater to the growing demand for environmentally conscious solutions, presenting an area ripe for innovation. Adversities such as complex sterilization processes and regulatory compliance hurdles require industry players to innovate continually and adapt to technological and procedural changes. For sustained growth, stakeholders should invest in research and development focusing on material science innovations and automate production processes to meet precision, scalability, and compliance needs. Overall, the market exhibits a dynamic landscape ripe with potential for growth, contingent on strategic operational adaptations and technological investments.

KEY MARKET STATISTICS
Base Year [2023] USD 797.79 million
Estimated Year [2024] USD 846.93 million
Forecast Year [2030] USD 1,253.88 million
CAGR (%) 6.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased demand from pharmaceutical and biotechnology industries
    • Growing initiatives from government and private organizations to advance vaccination
  • Market Restraints
    • Lack of healthcare infrastructure
  • Market Opportunities
    • Advancements in sterilization and depyrogenation technologies
    • Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials
  • Market Challenges
    • Risks associated with counterfeit products

Porter's Five Forces: A Strategic Tool for Navigating the Depyrogenated Sterile Empty Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Depyrogenated Sterile Empty Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Depyrogenated Sterile Empty Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Depyrogenated Sterile Empty Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Depyrogenated Sterile Empty Vials Market

A detailed market share analysis in the Depyrogenated Sterile Empty Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Depyrogenated Sterile Empty Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Depyrogenated Sterile Empty Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Depyrogenated Sterile Empty Vials Market

A strategic analysis of the Depyrogenated Sterile Empty Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Depyrogenated Sterile Empty Vials Market, highlighting leading vendors and their innovative profiles. These include Arab Pharmaceutical Glass Co. (APG), Bormioli Pharma, Consol Glass, Corning Inc., Gerresheimer AG, Global Pharmatech Pvt. Ltd., Hindusthan National Glass & Industries Ltd., Nipro Corporation, Piramal Glass, SCHOTT AG, SGD Pharma, SGD S.A.S, Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group, Thermo Fisher Scientific Inc., Triveni Polymers Pvt. Ltd., West Pharmaceutical Services, Inc., and YPSOMED AG.

Market Segmentation & Coverage

This research report categorizes the Depyrogenated Sterile Empty Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Glass Vials and Plastic Vials.
  • Based on Capacity, market is studied across 10mL, 20mL, 2mL, and 5mL.
  • Based on End-User, market is studied across Healthcare Institutions, Pharmaceutical Companies, and Research & Academic Labs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased demand from pharmaceutical and biotechnology industries
      • 5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of healthcare infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in sterilization and depyrogenation technologies
      • 5.1.3.2. Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with counterfeit products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding use of plastic vials due to their cost effective nature
    • 5.2.2. End-user: proliferating use of depyrogenated sterile empty vials in clinical research
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Depyrogenated Sterile Empty Vials Market, by Type

  • 6.1. Introduction
  • 6.2. Glass Vials
  • 6.3. Plastic Vials

7. Depyrogenated Sterile Empty Vials Market, by Capacity

  • 7.1. Introduction
  • 7.2. 10mL
  • 7.3. 20mL
  • 7.4. 2mL
  • 7.5. 5mL

8. Depyrogenated Sterile Empty Vials Market, by End-User

  • 8.1. Introduction
  • 8.2. Healthcare Institutions
  • 8.3. Pharmaceutical Companies
  • 8.4. Research & Academic Labs

9. Americas Depyrogenated Sterile Empty Vials Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Depyrogenated Sterile Empty Vials Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Depyrogenated Sterile Empty Vials Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. ALK Life Science Solutions Forms Strategic Partnership with Galenova for Distribution of Depyrogenated Sterile Empty Vials
    • 12.3.2. Corning and SGD Pharma Forge Strategic Alliance with New Glass Tubing Facility
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arab Pharmaceutical Glass Co. (APG)
  • 2. Bormioli Pharma
  • 3. Consol Glass
  • 4. Corning Inc.
  • 5. Gerresheimer AG
  • 6. Global Pharmatech Pvt. Ltd.
  • 7. Hindusthan National Glass & Industries Ltd.
  • 8. Nipro Corporation
  • 9. Piramal Glass
  • 10. SCHOTT AG
  • 11. SGD Pharma
  • 12. SGD S.A.S
  • 13. Shandong Pharmaceutical Glass Co., Ltd.
  • 14. Stevanato Group
  • 15. Thermo Fisher Scientific Inc.
  • 16. Triveni Polymers Pvt. Ltd.
  • 17. West Pharmaceutical Services, Inc.
  • 18. YPSOMED AG

LIST OF FIGURES

  • FIGURE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET RESEARCH PROCESS
  • FIGURE 2. DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEPYROGENATED STERILE EMPTY VIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH & ACADEMIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023